Skip to main content
Gulf Pharmaceutical Industries logo

Gulf Pharmaceutical Industries — Investor Relations & Filings

Ticker · JULPHAR ISIN · AEG000201018 Abu Dhabi Securities Exchange Manufacturing
Filings indexed 360 across all filing types
Latest filing 2019-02-07 Regulatory Filings
Country AE United Arab Emirates
Listing Abu Dhabi Securities Exchange JULPHAR

About Gulf Pharmaceutical Industries

https://www.Julphar.net

Gulf Pharmaceutical Industries (Julphar) is a prominent pharmaceutical manufacturer and distributor. The company specializes in producing a diverse portfolio of medicines, vaccines, and consumer healthcare products, addressing a broad spectrum of health conditions. Julphar is recognized as one of the largest generic pharmaceutical manufacturers in the Middle East and North Africa, and a leading global producer of insulin. Utilizing internationally accredited, state-of-the-art facilities, it manufactures over one million medicine boxes daily, distributing products to more than 40 countries. The company's operations emphasize high quality and safety standards in its comprehensive manufacturing capabilities.

Recent filings

Filing Released Lang Actions
JULPHAR Resumption
Regulatory Filings
2019-02-07 English
شركة الخليج للصناعات الدوائية نتائج اجتماع مجلس الإدارة 07/02/2019 الساعة 10:00
Regulatory Filings
2019-02-06 Arabic
Gulf Pharmaceutical Industries Board Meeting Results held on 07/02/2019 at 10:00
Regulatory Filings
2019-02-06 English
وقف التداول موقتا علي أسهم شركة شركة الخليج للصناعات الدوائية
Regulatory Filings Classification · 95% confidence The document is a formal resolution concerning the temporary suspension of trading on the shares of Gulf Pharmaceutical Industries. It references a specific regulatory article related to securities listing on ADX and details the suspension timing linked to a board meeting. The document is short (1817 characters) and is an official announcement about trading suspension, not a financial report, earnings release, or management discussion. It does not contain financial data, audit information, or voting results. It is a regulatory announcement related to trading status, which fits best under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories.
2019-02-04 Arabic
Temporary suspension of trading on the shares of Gulf Pharmaceutical Industries
Regulatory Filings Classification · 95% confidence The document is a formal resolution concerning the temporary suspension of trading on the shares of Gulf Pharmaceutical Industries (JULPHAR) by the Abu Dhabi Securities Exchange (ADX). It references regulatory articles about listing securities and specifies the suspension period tied to a board meeting. The document is an official announcement about trading suspension, not a financial report, earnings release, or management discussion. It does not contain financial data, audit information, or voting results. It is a regulatory announcement related to trading status, which fits best under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories.
2019-02-04 English
شركة الخليج للصناعات الدوائية اعلان اجتماع مجلس الإدارة بتاريخ 07/02/2019 الساعة 09:00
Regulatory Filings
2019-02-02 Arabic

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.